Related Experiment Video
Updated: Aug 13, 2025

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
Published on: July 3, 2015
Opioid-Modulated Receptor Localization and Erk1/2 Phosphorylation in Cells Coexpressing μ-Opioid and Nociceptin
Guan-Yu Zhuo1, Ming-Chi Chen1, Tzu-Yu Lin2
1Institute of Translational Medicine and New Drug Development, China Medical University, Taichung 40402, Taiwan.
Abstract:
We attempted to examine the alterations elicited by opioids via coexpressed μ-opioid (MOP) and nociceptin/orphanin FQ (NOP) receptors for receptor localization and Erk1/2 (p44/42 MAPK) in human embryonic kidney (HEK) 293 cells. Through two-photon microscopy, the proximity of MOP and NOP receptors was verified by fluorescence resonance energy transfer (FRET), and morphine but not buprenorphine facilitated the process of MOP-NOP heterodimerization. Single-particle tracking (SPT) further revealed that morphine or buprenorphine hindered the movement of the MOP-NOP heterodimers. After exposure to morphine or buprenorphine, receptor localization on lipid rafts was detected by immunocytochemistry, and phosphorylation of Erk1/2 was determined by immunoblotting in HEK 293 cells expressing MOP, NOP, or MOP+NOP receptors. Colocalization of MOP and NOP on lipid rafts was enhanced by morphine but not buprenorphine. Morphine stimulated the phosphorylation of Erk1/2 with a similar potency in HEK 293 cells expressing MOP and MOP+NOP receptors, but buprenorphine appeared to activate Erk1/2 solely through NOP receptors. Our results suggest that opioids can fine-tune the cellular localization of opioid receptors and phosphorylation of Erk1/2 in MOP+NOP-expressing cells.
Insights
Opioid drugs like morphine alter how μ-opioid (MOP) and nociceptin/orphanin FQ (NOP) receptors interact and move. Morphine enhances MOP-NOP receptor pairing and Erk1/2 phosphorylation, while buprenorphine primarily acts through NOP receptors.
Area of Science:
- Pharmacology
- Neuroscience
- Molecular Biology
Background:
- Opioid receptors, including μ-opioid (MOP) and nociceptin/orphanin FQ (NOP) receptors, play crucial roles in pain modulation and other physiological processes.
- Understanding the complex interactions and signaling pathways of coexpressed opioid receptors is essential for developing targeted therapeutics.
Purpose of the Study:
- To investigate the effects of opioids on the coexpression and heterodimerization of MOP and NOP receptors.
- To examine opioid-induced alterations in receptor localization on lipid rafts and Erk1/2 phosphorylation.
- To elucidate the distinct signaling mechanisms of morphine and buprenorphine through MOP and NOP receptors.
Main Methods:
- Utilized two-photon microscopy and fluorescence resonance energy transfer (FRET) to assess MOP-NOP receptor proximity and heterodimerization.
- Employed single-particle tracking (SPT) to analyze the movement of MOP-NOP heterodimers.
- Conducted immunocytochemistry and immunoblotting to determine receptor localization on lipid rafts and Erk1/2 phosphorylation in HEK 293 cells.
Main Results:
- Morphine, but not buprenorphine, facilitated MOP-NOP heterodimerization.
- Both morphine and buprenorphine reduced the mobility of MOP-NOP heterodimers.
- Morphine enhanced MOP-NOP colocalization on lipid rafts and stimulated Erk1/2 phosphorylation in cells expressing MOP or MOP+NOP receptors.
- Buprenorphine selectively activated Erk1/2 phosphorylation through NOP receptors.
Conclusions:
- Opioids can modulate the cellular localization and signaling of coexpressed MOP and NOP receptors.
- Morphine and buprenorphine exhibit distinct mechanisms in regulating MOP-NOP receptor complex dynamics and downstream signaling.
- These findings provide insights into the nuanced pharmacology of opioid receptor interactions and signaling pathways.
Related Concept Videos
Opioid Receptors: Overview
Analgesia and Pain Management
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Nociception
MAPK Signaling Cascades

